Personal Genome Diagnostics
AcquiredBaltimore, United States · Founded 2010 · $244.2M raised
- Headquarters
- Baltimore, Maryland
- Employees
- 51–200
- Founded
- 2010
- Business Model
- B2B
- Website
- personalgenome.com
- Total Funding
- $244.2M
- Last Round
- $103.0M Series CFeb 2021
- Rounds
- 5
About
Personal Genome Diagnostics (PGDx) develops comprehensive genomic profiling solutions for oncology, enabling clinicians and labs to rapidly detect actionable genomic alterations in solid tumors and liquid biopsies. Founded in 2010 by Johns Hopkins researchers, PGDx's elio portfolio includes tissue and plasma CGP solutions used in laboratories worldwide to close the precision oncology gap.
Summary
Personal Genome Diagnostics is a Biotech company based in Baltimore, United States, founded in 2010. It has raised $244.2M in total across 5 rounds, most recently a $103.0M Series C round in Feb 2021. Investors include New Enterprise Associates, Cowen Healthcare Investments and Innovatus Capital Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2022
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.